What HEMOLAB MEDICINA LABORATORIAL does

Hemolab Medicina Laboratorial is a Brazilian regional clinical pathology laboratory founded on January 15, 1998 in Conselheiro Lafaiete, Minas Gerais. The company operates a network of 13 physical laboratory units across 10 municipalities in Minas Gerais — six in Conselheiro Lafaiete (Matriz, Conceito, São João, São Sebastião, Jardim América, Chapada), two in Congonhas, and one each in Ouro Branco, Carandaí, Jeceaba, São Brás do Suaçuí, Santana dos Montes, Itaverava, and Entre Rios — supplemented by a mobile collection service (Atendimento Móvel) that visits patient homes and workplaces by appointment.

The core offering is comprehensive clinical laboratory testing across blood, urine, stool, semen, and other sample types using modern automated equipment, with technical quality verified through ISO 9001:2015 certification held continuously since 2008, and through external quality programs (PNCQ, SBAC, Control Lab). A portfolio of specialized add-on services sits on top of the core lab: vaccination following the SBIM calendar, structured check-up packages (men, women, children, STI, post-COVID, allergens), DNA paternity and genetic testing, DENATRAN-accredited toxicology for commercial drivers (categories C, D, E) executed in partnership with Hermes Pardini, non-invasive fetal sex determination (99.0% accuracy at ≥8 weeks gestation), newborn heel-prick screening, and veterinary diagnostics.

Revenue is generated on a per-transaction basis through a mix of health insurance reimbursement (convênios with major national operators and regional discount plans), direct patient pay, and B2B corporate contracts for occupational health, employee vaccination, and workplace screening. Since 2024, Hemolab has operated as a subsidiary of Grupo Fleury (B3: FLRY3), one of Brazil's largest diagnostic medicine groups with R$9 billion in full-year 2024 revenue, gaining access to advanced diagnostics, scientific research, and institutional quality infrastructure.

Name

HEMOLAB MEDICINA LABORATORIAL

Legal name

HEMOLAB MEDICINA LABORATORIAL

Website

https://hemolab.com.br

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Hemolab Medicina Laboratorial is a regional Brazilian clinical pathology laboratory founded in 1998, operating 13 units across 10 Minas Gerais municipalities. It serves individual patients, corporate occupational health clients, and commercial drivers with diagnostic testing, vaccination, mobile collection, and specialized add-ons, and is a subsidiary of Grupo Fleury since 2024.

Ownership category

akta.pro rank

Product category

Clinical Laboratory & Diagnostic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Hematology & Coagulation Laboratories (HLAFAMAC)

akta.pro secondary industries

Occupational Health & Employer Testing Laboratories (HLAFAMAK), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

Keywords

• Clinical laboratory services
• Diagnostic pathology testing
• Vaccination services
• Occupational health exams
• Molecular diagnostics

Headquarters

HQ city

Conselheiro Lafaiete

HQ country

Brazil

HQ region

Latin America

Offices15 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Laboratory Tests: Core revenue stream from performing laboratory tests including blood tests, urinalysis, stool analysis, and specialized diagnostics. Revenue generated per test through health insurance reimbursements and direct patient payment.
2. Vaccination Services: Vaccination services launched October 1, 2021, offering immunizations across all age groups following SBIM calendar. Revenue generated through per-vaccine fees.
3. Mobile Collection Service (Atendimento Móvel): Home and workplace sample collection service offered by appointment. Traditional scheduled collection is free; collection with specific time slot may incur displacement fee.
4. Check-up Packages: Pre-defined health check-up packages for men, women, children, post-COVID recovery, allergen testing, and sexual health screening sold as bundled offerings.
5. Toxicological Testing for CNH: Mandatory toxicological tests for driver's license (CNH) categories C, D, and E. Laboratory is DENATRAN-accredited, partnering with Hermes Pardini for analysis.
6. Corporate/Occupational Health Services: B2B services for companies including occupational health examinations, vaccination programs for employees, and health screening packages.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Hemolab Medicina Laboratorial is a clinical pathology laboratory network that performs diagnostic testing across blood, urine, feces, semen, and other sample types, complemented by vaccination services, mobile home/workplace collection, structured check-up packages, DNA/paternity testing, toxicology screening for driver's license holders, fetal sex determination, newborn heel-prick screening, and veterinary laboratory exams. The company operates 13 physical units across Minas Gerais municipalities and is a subsidiary of Grupo Fleury, one of Brazil's leading diagnostic medicine companies.

Product overview

Hemolab Medicina Laboratorial is a clinical pathology laboratory network serving the Conselheiro Lafaiete region of Minas Gerais, Brazil. The company operates as a unified laboratory services platform with a central matrix and multiple branch units. Its core product is Exames Laboratoriais (comprehensive clinical laboratory testing), which is complemented by specialized add-on services: Vacinas (vaccination), Atendimento Móvel (mobile home collection), Check-ups (structured health screening packages), DNA testing (paternity and genetic analysis), Exames Toxicológicos (DENATRAN-certified drug testing for drivers), Sexagem Fetal (fetal sex determination via maternal blood), Teste do Pezinho (newborn screening), and Exames Veterinários (veterinary diagnostics). The portfolio is unified under the Hemolab brand, with the vaccination service additionally branded as Hemolab Vacinas since October 2021.

Differentiator

Problem solved

Functional benefit

Brands

• Hemolab Vacinas: Vaccination service brand operated by Hemolab, offering immunization services following SBIM (Brazilian Immunization Society) calendar guidelines.

Quantifiable outcome

• 99.0% accuracy for fetal sexing test when gestational age is 8 weeks or more
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Four partnerships are on record, tiered flagship, core and supporting.

• Grupo FleuryflagshipStrategic or Co-development PartnerHemolab is part of Grupo Fleury, one of Brazil's most renowned diagnostic medicine and health companies with full-year revenue of R$ 9 billion in 2024. The acquisition brought Hemolab under the Fleury Group umbrella, providing institutional backing, quality standards, and access to advanced diagnostic capabilities and research. Grupo Fleury's CEO emphasizes 'consistency as an obsession' in the company's operations.
• Laboratório Hermes PardinicoreTechnology or IntegrationHemolab partners with Hermes Pardini for toxicological analysis for CNH (driver's license) testing. The partnership leverages Hermes Pardini's specialized toxicology laboratory capabilities while Hemolab handles sample collection and patient interface. This partnership enables Hemolab to offer DENATRAN-accredited toxicological testing required for categories C, D, and E driver's licenses.
• Health Insurance Operators (Multiple)coreChannel Partner/ Reseller/ DistributorHemolab accepts multiple major health insurance operators and regional discount plans including AISPEMG, ASAPEC, OAB, Saúde Card, SINDCOMERCIO, AMASPEM, ASPEMG, LAFPAX, Ouro Minas, and Rural Producers Syndicate. These partnerships are critical for patient acquisition and service delivery, with insurance reimbursements forming a significant portion of revenue.
• Sociedade Brasileira de Imunizações (SBIM)supportingStrategic or Co-development PartnerHemolab Vacinas follows the vaccination calendar suggested by SBIM (Sociedade Brasileira de Imunizações), aligning its immunization services with Brazilian medical society standards. The partnership ensures vaccination recommendations follow evidence-based guidelines for all age groups.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hermes Pardini: National Brazilian clinical laboratory group and Hemolab's partner for DENATRAN-accredited toxicology testing. Operates a comparable multi-specialty diagnostic testing portfolio and serves as Hemolab's reference lab partner.
• Sabin Medicina Diagnóstica: Brazilian diagnostic chain with a multi-unit regional-to-national footprint, offering clinical analysis, vaccination, check-ups, and corporate occupational health services — directly overlapping Hemolab's service portfolio.

Broad incumbents

• Grupo Fleury: Parent company of Hemolab and one of Brazil's largest diagnostic medicine operators (R$9B 2024 revenue, publicly traded on B3 as FLRY3). Comparable as a multi-unit clinical laboratory network serving both retail and corporate health segments across Brazil.
• Dasa: Largest diagnostic medicine company in Brazil, operating a national network of labs and brands (Delboni Auriemo, Salomão Zoppi, etc.). Comparable as a scaled clinical laboratory network pursuing regional consolidation through acquisitions similar to Hemolab.

Regional players

• DB Diagnósticos: Mid-sized regional diagnostic laboratory chain operating across Brazilian state capitals with a comparable mix of clinical analyses, vaccination, and corporate occupational health services.
• Weinmann Laboratórios: Regional clinical laboratory with multi-unit presence in southern Brazil (Rio Grande do Sul). Comparable in operating model — multi-site collection network serving B2C patients, physicians, and corporate clients.
• Laboratório Exame: Brazilian regional clinical laboratory offering routine diagnostics, vaccination, and check-up packages across multiple collection units. Comparable in portfolio breadth and customer segmentation.
• Alliança Laboratório: Brazilian regional clinical laboratory network operating across multiple municipalities with clinical analyses, vaccination, and corporate health services — overlapping with Hemolab's service model.
• Pasteur Medicina Diagnóstica: Brazilian regional diagnostic chain offering clinical analyses, vaccination, and corporate occupational health programs. Comparable service mix and multi-unit operating model to Hemolab.

Emerging players

• Centro de Diagnósticos Dr. Lídio Soncini: Smaller regional diagnostic center offering clinical analyses and complementary services such as vaccination and occupational health. Comparable as a regional lab operator targeting similar B2C and B2B segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/hemolab-laboratorio-de-patologia-clinica

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HEMOLAB MEDICINA LABORATORIAL